Clinical Trial Update: Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating axitinib given before surgery in high-risk prostate cancer patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Axitinib (Axitinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Stage III Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-03-07